The DOI matches its Crossref record; 78 of the 84 references it cites were found in a registry or an index.
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.
Open accessAbstract
Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein. Because no known kinase has been identified that can modify this site, HeLa nuclear extracts were fractionated and S20 phosphorylation was followed. We discovered that a S20 kinase activity copurifies with the human homolog of the Schizosaccharomyces pombe checkpoint kinase, Chk1 (hCHK1). We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase. It is interesting that hCHK1 strongly prefers tetrameric to monomeric p53 in vitro, consistent with our observation that phosphorylation of amino-terminal sites in vivo requires that p53 be oligomeric. Regulation of the levels and activity of hCHK1 in transfected cells is directly correlated with the levels of p53; expression of either a kinase-defective hCHK1 or antisense hCHK1 leads to reduced levels of cotransfected p53, whereas overexpression of wild-type hCHK1 or the kinase domain of hCHK1 results in increased levels of expressed p53 protein. The human homolog of the second S. pombe checkpoint kinase, Cds1 (CHK2/hCds1), phosphorylates tetrameric p53 but not monomeric p53 in vitro at sites similar to those phosphorylated by hCHK1 kinase, suggesting that both checkpoint kinases can play roles in regulating p53 after DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and hChk2, in turn, phosphorylates yet another amino-terminal Ser residue (Ser 20) in p53”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Shieh et al. 2000
In the citing paper
“These phosphorylation events contribute to disrupting the p53-Mdm2 (Chehab et al., 2000; Shieh et al., 2000), and Mdm2-DAXX (Tang et al., 2013) interactions, as well as to the degradation of Mdm2 and Mdm4 (Stommel and Wahl, 2004; Chen et al., 2005; Pereg et al., 2005, 2006; LeBron et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Shieh et al., 2000
In the citing paper
“p53 is phosphorylated at Ser20 by the checkpoint kinase Chk2 after IR, which results in p53's dissociation from Mdm2 and its subsequent stabilization”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Shieh et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Another p53 target gene, MDM2, encodes a p53-binding protein that negatively regulates the activity (Momand et al. 1992; Oliner et al. 1993) and the stability of p53 (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Self-citationEnhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citationOncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Flagged first, then by citations
6 of the 84 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mayo, 1997, Mdm2 phosphorylation by DNA-dependent protein kinase prevents ineraction with p53., Cancer Res., 57, 5013
Cited by
Sorted by citations
Items 501–600 of 964
Carr, M. I., Roderick, J. E., Gannon, H., Kelliher, M. A., & Jones, S. N. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.014 · Cited by 34
Parada, C. A., Osbun, J. W., Kaur, S., Yakkioui, Y., Shi, M. Y., Pan, C., Busald, T., Karasozen, Y., Gonzalez‐Cuyar, L. F., Rostomily, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19308-y · Cited by 34
Lee, S.-J., Lee, S.-H., Yoon, M.-H., & Park, B.-J. (2013) · Neoplasia · doi:10.1593/neo.121862 · Cited by 36
Hoogervorst, E. M., Bruins, W., Zwart, E., van Oostrom, C. T. M., van den Aardweg, G. J., Beems, R. B., van den Berg, J., Jacks, T., STEEG, H. V., & de Vries, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4328 · Cited by 34
Analysis of the CHK2 Gene in Lymphoid Malignancies
Tavor, S., Takeuchi, S., Tsukasaki, K., Miller, C. W., Hofmann, W. K., Ikezoe, T., SAID, J. W., & Koeffler, H. P. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109064610 · Cited by 34
The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
Chen, J. (2012) · Genes & Cancer · doi:10.1177/1947601912454733 · Cited by 33
Three independent mechanisms for arrest in G2after ionizing radiation
Landsverk, K. S., Patzke, S., Rein, I. D., Stokke, C., Lyng, H., Angelis, P. M. D., & Stokke, T. (2011) · Cell Cycle · doi:10.4161/cc.10.5.14968 · Cited by 35
High glucose induces mitochondrial p53 phosphorylation by p38 MAPK in pancreatic RINm5F cells
Flores-López, L. A., Díaz-Flores, M., García-Macedo, R., Ávalos‐Rodríguez, A., Vergara-Onofre, M., Cruz, M., Contreras‐Ramos, A., Königsberg, M., & Ortega‐Camarillo, C. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2595-2 · Cited by 33
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds
Siddiqui, R., Onel, K., Facio, F. M., Nafa, K., Díaz, L. R., Kauff, N. D., Huang, H. J., Robson, M. E., Ellis, N. A., & Offit, K. (2005) · Familial Cancer · doi:10.1007/s10689-004-1946-5 · Cited by 33
Low Frequency of CHEK2 Mutations in Familial Pancreatic Cancer
Bartsch, D. K., Krysewski, K., Sina‐Frey, M., Fendrich, V., Rieder, H., Langer, P., Kress, R., Schneider, M., Hahn, S. A., & Slater, E. P. (2006) · Familial Cancer · doi:10.1007/s10689-006-7850-4 · Cited by 33
UVB-Induced p21 degradation promotes apoptosis of human keratinocytes
Lei, X., Liu, B., Han, W., Ming, M., & He, Y. (2010) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00244e · Cited by 34
SMG7 is a critical regulator of p53 stability and function in DNA damage stress response
Luo, H., Cowen, L. E., Yu, G., Jiang, W. G., & Tang, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.42 · Cited by 33
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
Jethwa, A., Slabicki, M. M., Hüllein, J., Jentzsch, M., Dalal, V., Rabe, S., Wagner, L., Walther, T., Klapper, W., MMML Network Project, et al. (2018) · Blood · doi:10.1182/blood-2017-09-806679 · Cited by 37
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
Jackson, M. W., Agarwal, M. K., Agarwal, M. L., Agarwal, A. M., Stanhope-Baker, P., Williams, B. R. G., & Stark, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207575 · Cited by 33
Scott, S., O’Sullivan, M., Hafizi, S., Shapiro, L. M., & Bennett, M. R. (2002) · Circulation Research · doi:10.1161/hh0402.105900 · Cited by 33
Takagi, M. (2003) · Blood · doi:10.1182/blood-2003-01-0094 · Cited by 33
The relevance of protein-protein interactions for p53 function: the CPE contribution
Fernández-Fernández, M. R., & Sot, B. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq074 · Cited by 33
Hildesheim, J., & Fornace, A. J. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.02.012 · Cited by 32
Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis
Liang, M., Zhang, Y., Sun, C., Rizeq, F. K., Min, M., Shi, T., & Sun, Y. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0344-x · Cited by 33
Soubeyrand, S., Schild‐Poulter, C., & Haché, R. J. G. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04319.x · Cited by 33
Kim, C. J., Lee, J. H., Song, J. W., Cho, Y. G., Kim, S., Nam, S. W., Yoo, N. J., Park, W. S., & Lee, J. Y. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.02.007 · Cited by 32
Intrasteric regulation of MDM2
Shimizu, H., & Hupp, T. R. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00140-3 · Cited by 32
Katz, C., Low-Calle, A. M., Choe, J. H., Laptenko, O., Tong, D., Joseph-Chowdhury, J.-S. N., Garofalo, F., Zhu, Y. Y., Friedler, A., & Prives, C. L. (2018) · Genes & Development · doi:10.1101/gad.304071.117 · Cited by 32
Self-citationStability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456
Kass, E. M., Ahn, J., Tanaka, T., Freed-Pastor, W. A., Keezer, S. M., & Prives, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704642200 · Cited by 31
Self-citationNucleotide excision repair- and p53-deficient mouse models in cancer research
Hoogervorst, E. M., STEEG, H. V., & de Vries, A. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.01.018 · Cited by 31
CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11p110
Choi, H. J., Choi, H.-K., Jung, S. Y., Hyle, J. W., Kim, B., Yoon, K., Cho, E., Youn, H.-D., Lahti, J. M., Qin, J., et al. (2012) · Oncogene · doi:10.1038/onc.2012.535 · Cited by 32
Controlling the response to DNA damage by the APC/C-Cdh1
de Boer, H. R., Llobet, S. G., & van Vugt, M. A. T. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2096-7 · Cited by 32
Oishi, I., Iwai, K., Kagohashi, Y., Fujimoto, H., Kariya, K., Kataoka, T., Sawa, H., Okano, H., Otani, H., Yamamura, H., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1329-1335.2001 · Cited by 31
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma
Lipton, L. R., Fleischmann, C., Sieber, O. M., Thomas, H. J. W., Hodgson, S. V., Tomlinson, I. P. M., & Houlston, R. S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00391-4 · Cited by 31
Kang, H., Lim, J. W., & Kim, H. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.08.003 · Cited by 30
Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis
Mikawa, T., Shibata, E., Shimada, M., Ito, K., Ito, T., Kanda, H., Takubo, K., LLeonart, M. E., Inagaki, N., Yokode, M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101306 · Cited by 30
Controlling the Mdm2-Mdmx-p53 Circuit
Waning, D. L., Lehman, J. A., Batuello, C. N., & Mayo, L. D. (2010) · Pharmaceuticals · doi:10.3390/ph3051576 · Cited by 30
Effects of hyperthermia on p53 protein expression and activity
Guan, J., Stavridi, E. S., Leeper, D. B., & Iliakis, G. E. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10069 · Cited by 30
Activation of a DNA Damage Checkpoint Response in a TAF1-Defective Cell Line
Buchmann, A. M., Skaar, J. R., & DeCaprio, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5332-5339.2004 · Cited by 31
Yao, L.-M., He, J., Chen, H., Wang, Y., Wang, W., Wu, R., Yu, C., & Wu, Q. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr287 · Cited by 30
Tian, H., Faje, A. T., Lee, S. L., & Jorgensen, T. J. (2002) · Neoplasia · doi:10.1038/sj.neo.7900219 · Cited by 30
Burch, L. R., Shimizu, H., Smith, A. J., Patterson, C., & Hupp, T. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.017 · Cited by 30
Meng, L.-H., Kohn, K. W., & Pommier, Y. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210283 · Cited by 30
Spotlight on G-Quadruplexes: From Structure and Modulation to Physiological and Pathological Roles
dell’Oca, M. C., Quadri, R., Bernini, G. M., Menin, L., Grasso, L., Rondelli, D., Yazici, O., Sertic, S., Marini, F., Pellicioli, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063162 · Cited by 35
Overexpression of p53 protein in human tumors
Inoue, K., Kurabayashi, A., Shuin, T., Ohtsuki, Y., & Furihata, M. (2012) · Medical Molecular Morphology · doi:10.1007/s00795-012-0575-6 · Cited by 29
Interplay Between the Cell Cycle and Double-Strand Break Response in Mammalian Cells
Beishline, K., & Azizkhan‐Clifford, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_3 · Cited by 31
Checkpoint kinase 1 is essential for fetal and adult hematopoiesis
Schuler, F., Afreen, S., Manzl, C., Häcker, G. A., Erlacher, M., & Villunger, A. (2019) · EMBO Reports · doi:10.15252/embr.201847026 · Cited by 30
Momčilović, O., Navara, C. S., & Schatten, G. P. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_18 · Cited by 30
Ahn, J., Poyurovsky, M. V., Baptiste, N., Beckerman, R., Cain, C. R., Mattia, M., McKinney, K. M., Zhou, J., Zupnick, A., Gottifredi, V., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8548 · Cited by 30
Self-citationIslam, S., Qi, W., Morales, C., Cooke, L. S., Spier, C. M., Weterings, E., & Mahadevan, D. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0089 · Cited by 29
Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells
Rauch, A., Carlstedt, A., Emmerich, C., Mustafa, A. M., Göder, A., Knauer, S. K., Linnebacher, M., Heinzel, T., & Krämer, O. H. (2018) · Oncotarget · doi:10.18632/oncotarget.25600 · Cited by 29
Increased expression of CHK2 in human gastric carcinomas harboring p53 mutations
Shigeishi, H., Yokozaki, H., Oue, N., Kuniyasu, H., Kondo, T., Ishikawa, T., & Yasui, W. (2002) · International Journal of Cancer · doi:10.1002/ijc.10272 · Cited by 30
p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours
Camplejohn, R. S., & Rutherford, J. (2001) · Cell Proliferation · doi:10.1046/j.1365-2184.2001.00193.x · Cited by 29
Bean, L. J., & Stark, G. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108881200 · Cited by 29
CHEK2 1100delC is present in familial breast cancer cases of the Basque Country
Martínez-Bouzas, C., Beristain, E., Guerra, I., Gorostiaga, J. M., Mendizabal‐Zubiaga, J., De-Pablo, J.-L., García-Alegría, E., Sanz-Parra, A., & Tejada, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9351-4 · Cited by 29
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.
Tang, J., Agrawal, T., Cheng, Q., Qu, L., Brewer, M. D., Chen, J., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055813 · Cited by 28
Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus
Handke, W., Krause, E., & Brune, W. (2012) · Medical Microbiology and Immunology · doi:10.1007/s00430-012-0264-z · Cited by 28
Nishimura, K., Makino, S., Tanaka, Y., Kaneda, T., & Hashimoto, K. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01131.x · Cited by 28
Stochastic and Deterministic Models of Cellular p53 Regulation
Leenders, G. B., & Tuszyński, J. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00064 · Cited by 28
Wang, N., Ding, H., Liu, C., Li, X., Wei, L., Yu, J., Liu, M., Ying, M., Gao, W., Jiang, H., et al. (2015) · Oncogene · doi:10.1038/onc.2014.443 · Cited by 28
Genetic polymorphisms and endometrial cancer risk
Meyer, L. A., Westin, S. N., Lu, K. H., & Milam, M. R. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.7.1159 · Cited by 28
Targeting ATM pathway for therapeutic intervention in cancer
Khalil, H. S., Tummala, H., Chakarov, S., Zhelev, N., & Lane, D. P. (2012) · Biodiscovery · doi:10.7750/biodiscovery.2012.1.3 · Cited by 31
Pike, B. L., Hammet, A., & Heierhorst, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009558200 · Cited by 28
The Transcriptional Program following p53 ActivationPreprint
Zhao, R., Gish, K., Murphy, M. E., Yin, Y., Notterman, D. A., HOFFMAN, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.475 · Cited by 28
Therapeutic Strategies to Activate p53
Aguilar, A., & Wang, S. (2022) · Pharmaceuticals · doi:10.3390/ph16010024 · Cited by 28
Genetic changes and DNA damage responses in the prostate
af Hällström, T., & Laiho, M. (2008) · The Prostate · doi:10.1002/pros.20746 · Cited by 27
A Small Ras-like protein Ray/Rab1c modulates the p53-regulating activity of PRPK
Abe, Y., Takeuchi, T., Imai, Y., Murase, R., Kamei, Y., Fujibuchi, T., Matsumoto, S., Ueda, N., Ogasawara, M., Shigemoto, K., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.071 · Cited by 30
Gene‐specific mechanisms of p53 transcriptional control and prospects for cancer therapy
Resnick‐Silverman, L., & Manfredi, J. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20925 · Cited by 27
Kato, N., Fujimoto, H., Yoda, A., Oishi, I., Matsumura, N., Kondo, T., Tsukada, J., Tanaka, Y., Imamura, M., & Minami, Y. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401461 · Cited by 27
Effects of ethanol on hepatic cellular replication and cell cycle progression
Clemens, D. L. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i37.4955 · Cited by 27
Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability
Kim, Y.-Y., Park, B.-J., Kim, D. J., Kim, W.-H., Kim, S., Oh, K.-S., Lim, J.-Y., Kim, J., Park, C., & Park, S.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.014 · Cited by 27
The SKP2 ‐p27 axis defines susceptibility to cell death upon CHK1 inhibition
Lohmüller, M., Roeck, B. F., Szabó, T. G., Schapfl, M. A., Pegka, F., Herzog, S., Villunger, A., & Schuler, F. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13264 · Cited by 27
Biderman, L., Poyurovsky, M. V., Assia, Y., Manley, J. L., & Prives, C. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06150-11 · Cited by 27
Self-citationTimmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26
Lehrke, M. J., Shapiro, M. J., Rajcula, M. J., Kennedy, M. M., McCue, S. A., Medina, K. L., & Shapiro, V. S. (2021) · eLife · doi:10.7554/elife.69621 · Cited by 26
Chk2 Oligomerization Studied by Phosphopeptide Ligation
Li, J., Taylor, I. A., Lloyd, J., Clapperton, J. A., Howell, S. A., Macmillan, D., & Smerdon, S. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804075200 · Cited by 26
Wu, S., Wu, A. T. H., & Liu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.9856 · Cited by 26
Ensuring the Stability of the Genome: DNA Damage Checkpoints
Latif, C., Harvey, S. H., & O'Connell, S. J. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.297 · Cited by 26
DNA replication blockade impairs p53-transactivation
Takimoto, R., & El‐Deiry, W. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.781 · Cited by 26
The DNA Damage Checkpoint and Human CancerPreprint
Schultz, L. B., Chehab, N. H., Malikzay, A., DiTullio, R. A., Stavridi, E. S., & Halazonetis, T. D. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.489 · Cited by 26
Kim, B.-M., Choi, J. Y., Kim, Y. J., Woo, H. D., & Chung, H. W. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.053 · Cited by 26
Chen, Y., Miao, Z., Zhao, W., & Ding, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.053 · Cited by 25
Ubiquitin in Cell-Cycle Regulation and Dysregulation in Cancer
Borg, N. A., & Dixit, V. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075607 · Cited by 26
Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model
Kottemann, M. C., & Bale, A. E. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.06.001 · Cited by 25
Identification of CGI-121, a novel PRPK (p53-related protein kinase)-binding protein
Miyoshi, A., Kito, K., Aramoto, T., Abe, Y., Kobayashi, N., & Ueda, N. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00333-4 · Cited by 25
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
Berge, E. O., Staalesen, V., Straume, A. H., Lillehaug, J. R., & Lønning, P. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.005 · Cited by 27
Déry, U., & Masson, J. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.009 · Cited by 27
Tischkowitz, M. D., Yılmaz, A. U., Chen, L. Q., Karyadi, D. M., Novak, D. J., Kirchhoff, T., Hamel, N., Tavtigian, S. V., Kolb, S., Bismar, T. A., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.006 · Cited by 26
Einarsdóttir, K., Rosenberg, L., Humphreys, K., Bonnard, C., Palmgren, J., Li, Y., Li, Y., Chia, K. S., Liu, E. T., Hall, P. N., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1623 · Cited by 26
Regulation of p53 after Different Forms of Stress and at Different Cell Cycle StagesPreprint
Gottifredi, V., Shieh, S.-Y., & Prives, C. L. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.483 · Cited by 25
Self-citationMoxley, A. H., & Reisman, D. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3590 · Cited by 25
Tan, Y., Chen, Y., Yu, L., Zhu, H., Meng, X., Huang, X., Meng, L., Ding, M., Wang, Z., & Shan, L. (2010) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00699.x · Cited by 24
Gong, Q.-F., Liu, E., Xin, R., Huang, X., & Gao, N. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0757-x · Cited by 24
O’Nions, J., Turner, A., Craig, R., & Allday, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.01363-06 · Cited by 24
Thottassery, J. V., Westbrook, L., Someya, H., & Parker, W. B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0409 · Cited by 24
On the intrinsic disorder status of the major players in programmed cell death pathways
Uversky, A. V., Xue, B., Peng, Z., Kurgan, L., & Uversky, V. N. (2013) · F1000Research · doi:10.12688/f1000research.2-190.v1 · Cited by 23
Role of Chk1 and Chk2 in Ara‐C‐induced differentiation of human leukemia K562 cells
Takagaki, K., Katsuma, S., Kaminishi, Y., Horio, T., Tanaka, T., Ohgi, T., & Yano, J. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00821.x · Cited by 24
DNA Damage and Polyploidization
Chow, J. P. H., & Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0_4 · Cited by 24
Jiang, Z., Jin, T., Gao, F., Liu, J., Zhong, J., & Zhao, H. (2011) · Process Biochemistry · doi:10.1016/j.procbio.2011.02.023 · Cited by 23
Park, H. Y., Kim, M. K., Moon, S., Cho, Y.-H., & Lee, C. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00195.x · Cited by 23
Minimal role of base excision repair in TET-induced global DNA demethylation in HEK293T cells
Jin, C., Qin, T., Barton, M. C., Jelı́nek, J., & Issa, J. J. (2015) · Epigenetics · doi:10.1080/15592294.2015.1091145 · Cited by 23
Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer
Berkel, Ç., & Çaçan, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120029 · Cited by 23
A Fluid Salt-bridging Cluster and the Stabilization of p53
Lwin, T. Z., Durant, J. J., & Bashford, D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.080 · Cited by 23
Induction and Bypass of p53 during Productive Infection by Polyomavirus
Dey, D. C., Dahl, J., Cho, S., & Benjamin, T. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9526-9532.2002 · Cited by 23
Pharmacogenomics and Breast Cancer
Lymberis, S. C., Parhar, P. K., Katsoulakis, E., & Formenti, S. C. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.1.31.25686 · Cited by 23
Metadata
- Authors
- Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C.
- Affiliations
- Seisen University (JP)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-02-01
- Volume
- 14
- Issue
- 3
- Pages
- 289-300
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316358
- OpenAlex
- W2120921507
- Cited by
- 972
- References
- 84
- Citations by year
- 2026: 11 · 2025: 4 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 24 · 2014: 39 · 2013: 38 · 2012: 42
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Princess Takamatsu Cancer Research Fund
- National Institutes of Health (CA58316)
- National Cancer Institute (R37CA058316, R01CA058316, CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 phosphorylation, Chk1, Chk2, checkpoint kinase, DNA damage response, p53 oligomerization, p53 stabilization, Schizosaccharomyces pombe, kinase activity
- MeSH terms
- Checkpoint Kinase 1, DNA Damage, HeLa Cells, Humans, Phosphorylation, Protein Kinases, Recombinant Proteins, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Schizosaccharomyces pombe Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review